Novartis’ oncology research chief in China jumps to upstart EpimAb in Shanghai
China upstart EpimAb Biotherapeutics has wooed in a top researcher from Novartis as its first chief medical officer.
Bin Peng, who had been global chief …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
